Long-term effectiveness of infection and antibiotic control programs on the transmission of carbapenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex in central Taiwan

Medecine et Maladies Infectieuses

Volumn 45, Issue 7, 2015, Pages 264-272

  Chen, C H ^a,b   Lin, L C ^a   Chang, Y J ^a   Liu, C E ^a   Soon, M S ^a  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b HUNGKUANG UNIVERSITY   (Taiwan)

Author keywords

Acinetobacter calcoaceticus Acinetobacter baumannii; Antibiotic stewardship; Carbapenem resistance; Hand hygiene; Infection control

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CARBAPENEM DERIVATIVE; CEFEPIME; CEPHALOSPORIN; CHLORHEXIDINE; CILASTATIN PLUS IMIPENEM; MEROPENEM; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ANTIINFECTIVE AGENT;

ACCREDITATION; ACINETOBACTER CALCOACETICUS-BAUMANNII COMPLEX; ACINETOBACTER CALCOACETICUS-BAUMANNII COMPLEX BACTEREMIA; ACINETOBACTER INFECTION; ADULT; AGED; ANTIBIOTIC CONTROL PROGRAM; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIAL TRANSMISSION; CARBAPENEM RESISTANT ACINETOBACTER CALCOACETICUS-BAUMANNII COMPLEX; CARBAPENEM RESISTANT ACINETOBACTER CALCOACETICUS-BAUMANNII COMPLEX INFECTION; CHILD; CLINICAL EFFECTIVENESS; COMORBIDITY; CROSS-SECTIONAL STUDY; DRUG USE; FEMALE; HAND WASHING; HEALTH PROGRAM; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFECTION CONTROL; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PATIENT EDUCATION; PROTOCOL COMPLIANCE; SKIN MANIFESTATION; TAIWAN; TREND STUDY; ACINETOBACTER BAUMANNII; ACINETOBACTER CALCOACETICUS; ACINETOBACTER INFECTIONS; ADOLESCENT; ANTIBIOTIC RESISTANCE; CROSS INFECTION; TIME FACTOR; TRANSMISSION; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ACINETOBACTER BAUMANNII; ACINETOBACTER CALCOACETICUS; ACINETOBACTER INFECTIONS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; CARBAPENEMS; CHILD; CROSS INFECTION; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; TAIWAN; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84938342195     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2015.04.005     Document Type: Article

References (37)

1. Fournier PE, Richet H. The Epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis 2006;42:692-9.
2. Jawad A, Heritage J, Snelling AM, Gascoyne-Binzi DM, Hawkey PM. Influence of relative humidity and suspending menstrua on survival of Acinetobacter spp. on dry surfaces. J Clin Microbiol 1996;37:2881-7.
3. Playford EG, Craig JC, Iredell JR. Carbapenem-resistant Acinetobacter baumannii in intensive care unit patients: risk factors for acquisition, infection and their consequences. J Hosp Infect 2007;65:204-11.
4. Bernards AT, Harinck HI, Dijkshoorn L, van der Reijden TJ, van den Broek PJ. Persistent Acinetobacter baumannii? Look inside your medical equipment. Infect Control Hosp Epidemiol 2004;25:1002-4.
5. Zanetti G, Blanc DS, Federli I, Raffoul W, Petignat C, Maravic P, et al. Importation of Acinetobacter baumannii into a burn unit: a recurrent outbreak of infection associated with widespread environmental contamination. Infect Control Hosp Epidemiol 2007;28:723-5.
6. Kuo LC, Lai CC, Liao CH, Hsu CK, Chang YL, Chang CY, et al. Multidrugresistant Acinetobacter baumannii bacteraemia: clinical features, antibiotic therapy and outcome. Clin Microbiol Infect 2007;13:196-8.
7. Wu CJ, Lee HC, Lee NY, Shih HI, Ko NY, Wang LR, et al. Predominance of gram-negative bacilli and increasing antibiotic resistance in nosocomial bloodstream infections at a university hospital in Southern Taiwan, 1996-2003. J Microbiol Immunol Infect 2006;39:135-43.
8. Lee NY, Lee HC, Ko NY, Chang CM, Shih HI, Wu CJ, et al. Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia. Infect Control Hosp Epidemiol 2007;28:713-9.
9. Chen CH, Lin LC, Chang YJ, Huang CC, Liu CE, Young TG. Analysis of prognostic factors in 95 patients with Acinetobacter baumannii bacteremia. Infection 2003;31:331-5.
10. Chen CH, Huang CC. Molecular epidemiological study of clinical Acinetobacter baumannii isolates: phenotype switching of antibiotic resistance. Ann Clin Microbiol Antibiot 2013;12:21.
11. Apisarnthanarak A, Warren DK, Fraser VJ. Creating a cohort area to limit transmission of pandrug-resistant Acinetobacter baumannii in a Thai tertiary care center. Clin Infect Dis 2008;48:1487-8.
12. Karageorgopoulos DE, Falagas ME. current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet Infect Dis 2008;8:751-62.
13. Centers for Disease Control (Taiwan). Statistics of communicable diseases and surveillance report in Taiwan 2003; 2004 in English.
14. Centers for Disease Control (Taiwan). Statistics of communicable diseases and surveillance report in Taiwan 2012; 2013 in English.
15. Kuo SC, Lee YT, Yang SP, Chen CP, Chen TL, Hsieh SL, et al. Eradication of multidrug-resistant Acinetobacter baumannii from the respiratory tract with inhaled colistin methanesulfonate: a matched case-control study. Clin Microbiol Infect 2012;18:870-6.
16. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008;36:309-32.
17. Clinical Laboratory Standards Institute. Methods for dilution antibiotic susceptibility tests for bacteria that grow aerobically-seventh edition: approved standard M7-A7.; 2007.
18. Alkhenizan A, Shaw C. Impact of accreditation on the quality of healthcare services: a systematic review of the literature. Ann Saudi Med 2011;31:407-16.
19. Smits H, Supachutikul A, Mate KS. Hospital accreditation: lessons from low-and middle-income countries. Global Health 2014;10:65.
20. Maragakis LL, Perl TM. Acinetobacter baumannii: epidemiology, antibiotic resistance, and treatment options. Clin Infect Dis 2008;46:1254-63.
21. Wilks M, Wilson A, Warwick S, Price E, Kennedy D, Ely A, et al. Control of an outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus colonization and infection in an intensive care unit (ICU) without closing the ICU or placing patients in isolation. Infect Control Hosp Epidemiol 2006;27:652-8.
22. Rodríguez-Baño J, García L, Ramírez E, Martínez-Martínez L, Muniain MA, Fernández-Cuenca F, et al. Long-term control of hospital-wide, endemic multidrug-resistant Acinetobacter baumannii through a comprehensive "bundle" approach. Am J Infect Control 2009;37:715-22.
23. Hay A. Audit in infection control. J Hosp Infect 2006;62:270-7.
24. Sekimoto M, Imanaka Y, Kobayashi H, Okubo T, Kizu J, Kobuse H, et al. Impact of hospital accreditation on infection control programs in teaching hospitals in Japan. Am J Infect Control 2008;36:212-9.
25. Landelle C, Pagani L, Harbarth S. Is patient isolation the single most important measure to prevent the spread of multidrug-resistant pathogens? Virulence 2013;4:163-7.
26. Cheng VC, Tai JW, Chan WM, Lau EH, Chan JF, To KK, et al. Sequential introduction of single room isolation and hand hygiene campaign in the control of methicillin-resistant staphylococcus aureus in intensive care unit. BMC Infect 2010;10:263-72.
27. Gbaguidi-Haore H, Legast S, Thouverez M, Bertrand X, Talon D. Ecological study of the effectiveness of isolation precautions in the management of hospitalized patients colonized or infected with Acinetobacter baumannii. Infect Control 2008;29:1118-23.
28. Goel N, Wattal C, Oberoi JK, Raveendran R, Datta S, Prasad KJ. Trend analysis of antibiotic consumption and development of resistance in nonfermenter in a tertiary care hospital in Delhi, India. J Antimicrob Chemother 2011;66:1625-30.
29. Karageorgopoulos DE, Falagas ME. Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet Infect Dis 2008;8:751-62.
30. Lee K, Yong D, Jeong SH, Chong Y. Multidrug-resistant acinetobacter spp increasingly problematic nosocomial pathogens. Yonsei Med J 2011;52:879-91.
31. Marchaim D, Zaidenstein R, Lazarovitch T, Karpuch Y, Ziv T, Weinberger M. Epidemiology of bacteremia episodes in a single center: Increase in gram-negative isolates, antibiotics resistance, and patient age. Eur J Clin Microbiol Infect Dis 2008;27:1045-51.
32. Jang TN, Lee SH, Huang CH, Lee CL, Chen WY. Risk factors and impact of nosocomial Acinetobacter baumannii bloodstream infections in the adult intensive care unit: a case-control study. J Hosp Infect 2009;73:143-50.
33. Jamulitrat S, Arunpan P, Phainuphong P. Attributable mortality of imipenem-resistant nosocomial Acinetobacter baumannii bloodstream infection. J Med Assoc Thai 2009;92:413-9.
34. Tacconelli E, Cataldo MA, Dancer SJ, De Angelis G, Falcone M, Frank U, et al. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant gram-negative bacteria in hospitalized patients. Clin Microbiol Infect 2014;20:S1-55 Supple.
35. Marchaim D, Navon-Venezia S, Leavitt A, Chmelnitsky I, Schwaber MJ, Carmeli Y. Molecular and epidemiologic study of polyclonal outbreaks of multidrug-resistant Acinetobacter baumannii infection in an Israeli hospital. Infect Control Hosp Epidemiol 2007;28:945-50.
36. Kochar S, Sheard T, Sharma R, Hui A, Tolentino E, Allen G, et al. Success of an infection control program to reduce the spread of carbapenemresistant klebsiella pneumoniae. Infect Control Hosp Epidemiol 2009;30: 447-52.
37. Barbolla RE, Centron D, Maimone S, Rospide F, Salgueira C, Altclas J, et al. Molecular epidemiology of Acinetobacter baumannii spread in an adult intensive care unit under an endemic setting. Am J Infect Control 2008;36:444-52.